New process for the synthesis of UP 269-6, a 1,2,4-triazolo[1,5-c]pyrimidine derivative as a potent orally active angiotensin II antagonist

Journal of Heterocyclic Chemistry

Volumn 33, Issue 4, 1996, Pages 1307-1311

  Boyer, T ^a   Fournel, L ^a   Nicolai E ^a   Teulon, J M ^a  

^a UPSA Laboratories   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN ANTAGONIST;

ARTICLE; DRUG SYNTHESIS; REACTION ANALYSIS;

EID: 0029823548     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570330450     Document Type: Article

References (8)

1. [1a] E. Nicolaï, G. Curé, J. Goyard, M. Kirchner, J. M. Teulon, A. Versigny, M. Cazes, F. Caussade, A. Virone-Oddos and A. Cloarec, J. Med. Chem., 37, 2371 (1994)
2. [b] N. Bru-Magniez, E. Nicolaï and J. M. Teulon, US Patent 5,217,973 (1993).
3. [2a] F. Caussade, A. Virone-Oddos, C. Delchambre, M. Cazes, A. Versigny and A. Cloarec, Fundam. Clin. Pharmacol., 9, 119 (1995)
4. [b] M. Mcintyre, R.J. McFadyen, P.A. Meredith, J. Menard, H.R. Brunner, J. Insuasty and J. L. Reid, J. Cardiovasc, Pharmacol., 25, 994 (1995)
5. [c] N. Inglessis, J. Nussberger, M. Hagmann, O. Hiesse-Provot, J. Insuasty, J. Reid, J. Menard and H.R. Brunner, J. Cardiovasc. Pharmacol., 25, 986 (1995).
6. Y. Sung-Eun and Y .Y. Kyu, Bull. Korean Chem. Soc., 10 112 (1989).
7. [4a] G. W. Miller, F. L. Rose, J. Chem. Soc., 5642 (1963)
8. [b] G. W. Miller and F. L. Rose, J. Chem. Soc., 3357 (1965).